Mentored Patient-Oriented Research Career Development Award

Status:

UNKNOWN

Mentored Patient-Oriented Research Career Development Award

Lead Sponsor:

University of California, Los Angeles

Conditions:

Asthma

Distal Lung Inflammation

Eligibility:

All Genders

18-50 years

Phase:

PHASE1

PHASE2

Brief Summary

Asthmatics have inflammation in the large airways (tubes through which air travels in and out of the lungs). The large airways are located in the central lung. New research shows that asthmatics also ...

Eligibility Criteria

Inclusion

Aged 18 to 50 years. Younger subjects are excluded due to greater concerns with respect to risks from radiation and bronchoscopy in children; older subjects due to greater risks of bronchoscopy.
Mild to moderate persistent asthma (forced expiratory volume in 1 second \[FEV1\] greater than or equal to 70% predicted {Hankinson, 1999 #266}; PC20 less than or equal to 8 mg/ml) and currently using only short acting inhaled beta agonists as needed for control of asthma symptoms.

Exclusion

The use of the following medications will exclude subjects from entering the study:
Oral or parenteral steroids within 6 months
Inhaled corticosteroids within 3 months
Antileukotrienes, b-adrenergic blocking agents, inhaled cromolyn sodium or nedocromil, macrolide antibiotics, or investigational drugs within 1 month
Drugs or exposures which, in the opinion of the investigators, could influence study results
Tobacco within 1 year or less than or equal to 5 pack years.
Pregnant women, lactating women, or women of childbearing age not willing to take precautions to avoid becoming pregnant during the study.
Subjects with upper respiratory infection or receiving an influenza vaccine within 6 weeks of the study.
Subjects with a history of allergy or adverse reaction to inhaled beta agonists or methacholine.
Subjects with clinically significant evidence of cardiovascular, central nervous system, endocrine, gastrointestinal, hematopoietic, hepatic, psychiatric, or respiratory (other than asthma) disease
Eligibility will be determined by an investigator using the above inclusion/exclusion criteria.
No subjects will be excluded based on race or gender. Subjects must be between 18 and 50 in order to avoid greater risks of bronchoscopy and, in those under 18, exposure to radiation. To avoid risks, women will not be enrolled if pregnant, lactating or of childbearing potential and unwilling to undertake appropriate precautions.

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00203684

Last Update

February 17 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)